首页 > 市场调查报告书 > 食物/饮料

调味料

市场调查报告书

商品编码

1524318

塔格糖市场规模 - 按类型（L-塔格糖、D-塔格糖）应用（食品和饮料、药品、个人护理、动物饲料、其他）配销通路（线上零售、专卖店、直销）和预测，2024 - 2032

Tagatose Market Size - By Type (L-Tagatose, D-tagatose) Application (Food & beverages, Pharmaceuticals, Personal care, Animal Feed, Others) Distribution Channel (Online retail, Specialty store, Direct sales) & Forecast, 2024 - 2032

出版日期: 2024年04月17日 | 出版商:

Global Market Insights Inc. | 英文 305 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在健康意识不断提升的推动下，全球塔格糖市场预计 2024 年至 2032 年间复合年增长率将超过 4.7%。人们对健康益处的认识不断提高以及对低热量甜味剂的需求是市场的关键催化剂。这种天然甜味剂以其低热量和益生元特性而闻名，越来越多地用于食品和饮料行业。不断增加的糖尿病负担正在推动预测期内对塔格糖的需求。根据 IDF 糖尿病图谱，10.5% 的成年人（20-79 岁）患有糖尿病，其中近一半人不知道自己的病情。预计到 2045 年，每 8 名成年人中就有 1 人（即约 7.83 亿人）患有糖尿病，增幅为 46%。

糖尿病患者需要低升糖指数的替代品，并发现塔格糖适合食用。生产技术的进步也使塔格糖更具成本效益，而消费者对天然成分的偏好和功能性食品的兴起开闢了新的市场途径。这些因素共同加强了塔格糖市场的成长。

整个塔格糖产业根据类型、应用、配销通路和地区进行分类。

由于其潜在的治疗功效，到 2032 年，製药领域将占据重要的塔格糖市场。其益生元特性可增强肠道健康，支持其在消化保健补充剂中的应用。此外，塔格糖在控制高血糖和代谢紊乱方面显示出前景，这使其对于糖尿病相关的治疗很有价值。其低升糖指数和对血糖值的影响极小，使其成为糖尿病患者药物中的安全成分。对塔格糖抗氧化和抗发炎特性的持续研究表明其在更广泛的製药应用中的潜力，从而迎来了对其的需求。

L-塔格糖细分市场从 2024 年到 2032 年将呈现出有希望的复合年增长率，因为其独特的代谢途径使其能够被人体最小化吸收，从而降低血糖水平。这一特性使其非常适合体重管理和肥胖预防。此外，L-塔格糖天然存在于乳製品和水果中，吸引了寻求正宗、加工较少成分的消费者。由于其非致龋性，随着消费者越来越重视口腔健康和整体福祉，其在牙齿保健产品中的应用增加了其需求。

由于人们越来越关注永续和天然成分，欧洲塔格糖市场将在 2032 年蓬勃发展，其 CGAR 值得关注。欧洲消费者的健康意识越来越强，因此更偏好塔格糖等低热量和低血糖甜味剂。此外，对人造甜味剂的严格监管以及对清洁标籤产品的大力推动促使製造商选择天然替代品。欧洲功能性食品和饮料市场的不断升级促进了需求，因为塔格糖符合增强健康成分的趋势。

产业生态系统分析
- 价值链
- 主要製造商
- 前往市场路线
- 主要经销商
  - 新的分销管道
- 全行业利润率
产业影响力
- 成长动力
  - 对天然成分的需求
  - 增强健康意识
  - 产品创新及多元化
- 产业陷阱与挑战
  - 来自现有甜味剂的竞争
  - 生产成本高
- 市场机会
  - 新市场/新应用
  - 成长潜力分析
原料景观
- 製造趋势
  - 技术演进
  - 永续製造
    - 绿色实践
    - 脱碳
- 新原料
- 原物料价格走势（美元/吨）
  - 我们
  - 欧洲联盟
  - 英国
  - 中国
  - 东南亚
  - 海湾合作委员会
法规和市场影响
贸易统计
未满足的需求
波特的分析
PESTEL分析

第 4 章：竞争格局

公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场规模与预测：按类型，2021-2032

主要趋势
L-塔格糖
D-塔格糖

第 6 章：市场规模与预测：按应用划分，2021-2032 年

主要趋势
食品与饮品
製药
个人护理
动物饲料
其他

第 7 章：市场规模与预测：按配销通路，2021-2032 年

主要趋势
网路零售
专卖店
直销

第 8 章：市场规模与预测：按地区划分，2021-2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 澳洲
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
MEA
- 沙乌地阿拉伯
- 阿联酋
- 南非
- MEA 的其余部分

第 9 章：公司简介

Alfa chemistry
Bio sugar technology
BLD pharm
Bonumose LLC
Chemily glycosciece
Merck
Ottokemi pvt ltd
Santa cruz biotechnology
Spectrum chemical
Syngars
Tokyo Chemical Industry
Zhejiang yixin pharamceutical co ltd

简介目录

Product Code: 9086

Global Tagatose Market will infer over 4.7% CAGR between 2024 and 2032, driven by escalating health consciousness. Rising awareness of health benefits and the demand for low-calorie sweeteners are key catalysts of the market. This natural sweetener, known for its low caloric content and prebiotic properties, is increasingly used in the food and beverage industry. The ever-growing burden of diabetes is propelling the demand for tagatose during the forecast period. As per the IDF Diabetes Atlas, 10.5% of adults (20-79 years) have diabetes, with nearly half unaware of their condition. By 2045, projections indicate that 1 in 8 adults, or about 783 million, will have diabetes, a 46% increase.

Diabetic people require low glycemic index alternatives and find Tagatose suitable for consumption. Technological advancements in production have also made Tagatose more cost-effective, while consumer preference for natural ingredients and the rise of functional foods have opened new market avenues. These factors collectively strengthen the growth of the tagatose market.

The overall tagatose industry is sorted based on type, application, distribution channel, and region.

The pharmaceuticals segment will clutch a significant tagatose market share by 2032 because of its potential therapeutic benefits. Its prebiotic properties enhance gut health, supporting its use in digestive health supplements. Additionally, Tagatose shows promise in managing hyperglycemia and metabolic disorders, making it valuable for diabetes-related treatments. Its low glycemic index and minimal impact on blood sugar levels make it a safe ingredient in medications for diabetic patients. Ongoing research into Tagatose's antioxidant and anti-inflammatory properties suggests its potential in broader pharmaceutical applications, ushering in its demand.

The L-Tagatose segment will exhibit a promising CAGR from 2024 to 2032, owing to its unique metabolic pathway, which allows it to be minimally absorbed by the body, resulting in lower blood sugar levels. This characteristic makes it highly desirable for weight management and obesity prevention. Additionally, L-Tagatose's natural occurrence in dairy products and fruits appeals to consumers seeking authentic, less processed ingredients. Due to its non-cariogenic nature, its application in dental health products boosts its demand as consumers increasingly prioritize oral health and overall well-being.

Europe tagatose market thrives with a noteworthy CGAR through 2032 due to the increasing focus on sustainable and natural ingredients. European consumers are becoming more health-conscious, leading to a higher preference for low-calorie and low-glycemic sweeteners like Tagatose. Additionally, stringent regulations on artificial sweeteners and a strong push towards clean-label products proliferate manufacturers to opt for natural alternatives. The escalating market for functional foods and beverages in Europe contributes to the demand, as Tagatose aligns with trends for health-enhancing ingredients.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Data Mining sources
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis
2.2 Type trends
2.3 Application trends
2.4 Distribution channel trends

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Value chain
- 3.1.2 Key manufacturers
- 3.1.3 Go to market routes
- 3.1.4 Key distributors
  - 3.1.4.1 New distribution channels
- 3.1.5 Profit margins across the industry
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Demand for natural ingredients
  - 3.2.1.2 Increasing health consciousness
  - 3.2.1.3 Product innovation and diversification
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1. Competition from existing sweeteners
  - 3.2.2.2. High production cost
- 3.2.3 Market opportunities
  - 3.2.3.1 New markets/applications
  - 3.2.3.2 Growth potential analysis
3.3 Raw material landscape
- 3.3.1 Manufacturing trends
  - 3.3.1.1 Technology evolution
  - 3.3.1.2 Sustainable manufacturing
    - 3.3.1.2.1 Green practices
    - 3.3.1.2.2 Decarbonization
- 3.3.2 New raw materials
- 3.3.3 Raw material pricing trends (USD/Ton)
  - 3.3.3.1 U.S.
  - 3.3.3.2 European Union
  - 3.3.3.3 UK
  - 3.3.3.4 China
  - 3.3.3.5 Southeast Asia
  - 3.3.3.6 GCC
3.4 Regulations & market impact
3.5 Trade statistics
3.6 Unmet needs
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Company market share analysis
4.2 Competitive positioning matrix
4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Type, 2021-2032 (USD Million, Kilo Tons)

5.1 Key trends
5.2 L-Tagatose
5.3 D-Tagatose

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Kilo Tons)

6.1 Key trends
6.2 Food and beverage
6.3 Pharmaceutical
6.4 Personal care
6.5 Animal feed
6.6 Other

Chapter 7 Market Size and Forecast, By Distribution Channel, 2021-2032 (USD Million, Kilo Tons)

7.1 Key trends
7.2 Online retail
7.3 Specialty store
7.4 Direct sale

Chapter 8 Market Size and Forecast, By Region, 2021-2032 (USD Million, Kilo Tons)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 Australia
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 MEA
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 South Africa
- 8.6.4 Rest of MEA